SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025138
Filing Date
2020-05-13
Accepted
2020-05-13 17:21:54
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20200331.htm 10-Q 1452394
2 EX-31.1 tcon-ex311_7.htm EX-31.1 9261
3 EX-32.1 tcon-ex321_6.htm EX-32.1 5612
  Complete submission text file 0001564590-20-025138.txt   4577674

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20200331.xml EX-101.INS 732980
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20200331.xsd EX-101.SCH 52282
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20200331_cal.xml EX-101.CAL 35045
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20200331_def.xml EX-101.DEF 134369
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20200331_lab.xml EX-101.LAB 335981
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20200331_pre.xml EX-101.PRE 238737
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 20874277
SIC: 2836 Biological Products, (No Diagnostic Substances)